» Articles » PMID: 17603547

Novel Uses for Anti-platelet Agents As Anti-inflammatory Drugs

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2007 Jul 3
PMID 17603547
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

An alteration in the character and function of platelets is manifested in patients with inflammatory diseases, and these alterations have been dissociated from the well-characterized involvement of platelets in thrombosis and haemostasis. Recent evidence reveals platelet activation is sometimes critical in the development of inflammation. The mechanisms by which platelets participate in inflammation are diverse, and offer numerous opportunities for future drug intervention. There is now acceptance that platelets act as innate inflammatory cells in immune responses, with roles as sentinel cells undergoing surveillance, responding to microbial invasion, orchestrating leukocyte recruitment, and migrating through tissue, causing damage and influencing repair processes in chronic disease. Some of these processes are targeted by drugs that are being developed to target platelet participation in atherosclerosis. The actions of platelets therefore influence the pathogenesis of diverse inflammatory diseases in various body compartments, encompassing parasitic and bacterial infection, allergic inflammation (especially asthma and rhinitis), and non-atopic inflammatory conditions, for example, chronic obstructive pulmonary disease (COPD), rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and atherosclerosis. This review will first discuss the evidence for platelet activation in these various inflammatory diseases, and secondly discuss the mechanisms by which this pathogenesis occurs and the various anti-platelet agents which have been developed to combat platelet activation in atherosclerosis and their potential future use for the treatment of other inflammatory diseases.

Citing Articles

Ulcerative colitis and thrombocytosis: Case report and literature review.

Zhou Y, Zhu F, Jing D, Wang Q, Zhou G Medicine (Baltimore). 2023; 102(20):e33784.

PMID: 37335733 PMC: 10194520. DOI: 10.1097/MD.0000000000033784.


Platelets: a potential role in chronic respiratory diseases?.

Chebbo M, Duez C, Alessi M, Chanez P, Gras D Eur Respir Rev. 2021; 30(161).

PMID: 34526315 PMC: 9488457. DOI: 10.1183/16000617.0062-2021.


The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma.

Kim S, Trinh H, Park H, Shin Y Clin Mol Allergy. 2021; 19(1):11.

PMID: 34256766 PMC: 8275907. DOI: 10.1186/s12948-021-00149-6.


Antiplatelet agents'-ticagrelol and eptifibatide-safety in experimental colitis in mice.

Petrovic S, Vasiljevska M, Obradovic S, Tarabar D, Doder R, Majstorovic I Turk J Gastroenterol. 2020; 31(6):451-458.

PMID: 32721916 PMC: 7433996. DOI: 10.5152/tjg.2020.19454.


The Inhibition of P-Selectin Reduced Severe Acute Lung Injury in Immunocompromised Mice.

Liu Y, Xiang D, Gao F, Yao H, Ye Q, Wang Y Oxid Med Cell Longev. 2020; 2020:8430465.

PMID: 32377309 PMC: 7196163. DOI: 10.1155/2020/8430465.


References
1.
Evangelista V, Pamuklar Z, Piccoli A, Manarini S, DellElba G, Pecce R . Src family kinases mediate neutrophil adhesion to adherent platelets. Blood. 2006; 109(6):2461-9. PMC: 1852189. DOI: 10.1182/blood-2006-06-029082. View

2.
Cumashi A, Ushakova N, Preobrazhenskaya M, DIncecco A, Piccoli A, Totani L . A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology. 2007; 17(5):541-52. DOI: 10.1093/glycob/cwm014. View

3.
Yeo E, Sheppard J, Feuerstein I . Role of P-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model). Blood. 1994; 83(9):2498-507. View

4.
Daniel T, Liu H, Morrow J, Crews B, Marnett L . Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Cancer Res. 1999; 59(18):4574-7. View

5.
Leon C, Alex M, Klocke A, Morgenstern E, Moosbauer C, Eckly A . Platelet ADP receptors contribute to the initiation of intravascular coagulation. Blood. 2003; 103(2):594-600. DOI: 10.1182/blood-2003-05-1385. View